Kansa w'omu lubuto y'esobola okutta omuntu wa ngeri ki?
Kansa w'omu lubuto bulwadde bwa maanyi era busobola okutta omuntu.
Kye kirwadde kya kkansa ekisinga okusaasaana mu bakazi mu nsi yonna era kye ky'okubiri ekiviirako abakazi okufa okuva mu kkansa.
Okusinziira ku kibiina kya American Cancer Society, mu 20220, omuwendo gw'abakazi abafuna kookolo w'omu lubuto oguyitibwa invasive breast cancer gwogerwako nga 276,480 mu Amerika, era abakazi nga 42,170 mu Amerika baafa okuva ku kookolo w'omu lubuto.
Kyokka, omuwendo gw'abafa okuva ku kookolo w'omu lubuto gukendedde okuva mu 1989, n'okukendeera kwa 40% mu muwendo gw'abafa okuva ku kookolo w'omu lubuto okuva mu 1989 okutuuka mu 2017, okusingira ddala olw'okulongoosebwa mu kukebera n'okujjanjaba.
van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL: Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer. 2011, 104 (6): 910-4.
DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL: Breast cancer statistics, 2019. CA Cancer J Clin. 2019, 69 (6): 438-451.
Icaza G, Núñez L, Bugueño H: [Epidemiological analysis of breast cancer mortality in women in Chile]. Rev Med Chil. 2017, 145 (1): 106-114.
Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles EA: Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging. J Am Coll Radiol. 2017, 14 (9): 1137-1143.
Deaths from breast cancer--United States, 1991. MMWR Morb Mortal Wkly Rep. 1994, 43 (15): 273, 279-81.
Kuroishi T, Hirose K, Suzuki T, Tominaga S: Effectiveness of mass screening for breast cancer in Japan. Breast Cancer. 2000, 7 (1): 1-8.
Okwewala obuvunaanyizibwa: eby'obujjanjabi
Omukutu guno guweereddwa olw'ebigendererwa by'enjigiriza n'obubaka bwokka era teguwa kubuulirira kw'ekisawo oba obuweereza bw'ekikugu.
Obubaka obuweereddwa tebusaanidde kukozesebwa okuzuula oba okujjanjaba bulwadde, era abo abanoonya amagezi g'ekisawo balina okwebuuza ku musawo alina layisensi.
Weetegereze nti enkola ya neural net ekola eby'okuddamu mu bibuuzo, si ntuufu nnyo bwe kituuka ku muwendo gw'abantu. Ng'ekyokulabirako, omuwendo gw'abantu abalwadde obulwadde obumu.
Bulijjo noonya amagezi g'omusawo wo oba omusawo omulala omutuufu ku bikwata ku mbeera y'obulamu. Teweerabira magezi g'omusawo oba okulwawo okuganoonya olw'ekintu ky'osomye ku mukutu guno. Bw'oba olowooza oyinza okuba n'embeera ey'amangu mu by'obulamu, yita 911 oba genda mu ddwaaliro ly'amangu erisinga okumpi amangu ddala. Tewali nkolagana ya musawo n'omulwadde ekolebwa ku mukutu guno oba okukozesawo. BioMedLib oba abakozi baagwo, oba omuntu yenna ayamba ku mukutu guno, talina ky'agamba, ekyogamba oba ekiteeberezebwa, ku bikwata ku bubaka obuli wano oba okukozesawo.
Okwewala obuvunaanyizibwa: eddembe ly'okuwandiika
Digital Millennium Copyright Act ey'omwaka 1998, 17 U.S.C. § 512 (DMCA) ewa abalina eddembe ly'okuwandiika ebitabo abakkiriza nti ebintu ebiri ku mutimbagano bikontana n'eddembe lyabwe wansi w'amateeka g'eddembe ly'okuwandiika ebitabo mu Amerika.
Bw'oba olowooza mu bwesimbu nti ebintu oba ebintu ebikolebwa ku mukutu gwaffe ogwa webusayiti oba obuweereza bikontana n'amateeka go ag'eddembe ly'obuntu, ggwe (oba omubaka wo) osobola okututumira obubaka ng'osaba ebintu oba ebintu ebyo biggyibwe, oba okukugira.
Okumanyisa kulina okusindikibwa mu buwandiike nga bakozesa e-mail (laba ekitundu "Contact" ku adirisa ya e-mail) .
DMCA yeetaaga nti ekiwandiiko kyo eky'okuvumirira obutali bwenkanya bw'eddembe ly'obuntu kitwaliramu obubaka buno: (1) okunnyonnyola omulimu oguli wansi w'eddembe ly'obuntu ogugambibwa obutali bwenkanya; (2) okunnyonnyola ebintu ebigambibwa obutali bwenkanya n'obubaka obumala okutusobozesa okuzuula ebintu ebyo; (3) obubaka bw'okuwuliziganya naawe, nga mw'otwalidde endagiriro yo, ennamba ya ssimu n'ennamba ya e-mail; (4) ekiwandiiko okuva gy'oli ekiraga nti olina okukkiriza okutuufu nti ebintu mu ngeri ey'okwemulugunya tebikkirizibwa nnannyini ddembe ly'obuntu, oba omubaka we, oba mu nkola y'amateeka.
(5) ekiwandiiko ky'oyimirizza, wansi w'omusango gw'okubuusabuusa, nti obubaka obuli mu kiwandiiko kituufu era nti olina obuyinza okussa mu nkola eddembe ly'okuwandiika erigambibwa okuba nga lyamenyebwa;
era (6) omukono ogw'omubiri oba ogw'oku mutimbagano ogwa nnannyini copyright oba omuntu ow'obuyinza okukolera mu linnya lya nnannyini copyright.
Breast cancer is a serious and potentially deadly disease.
It is the most common cancer among women worldwide and the second leading cause of cancer death in women.
According to the American Cancer Society, in 20220, an estimated 276,480 new cases of invasive breast cancer were diagnosed in women in the United States, and about 42,170 women in the U.S. died from breast cancer.
However, the death rate from breast cancer has been declining since 1989, with a 40% decrease in the breast cancer death rate from 1989 to 2017, largely due to improvements in early detection and treatment.
The risk of dying from breast cancer varies depending on factors such as age, stage at diagnosis, and the type of breast cancer.
Early detection and treatment can significantly improve the chances of survival.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
